Patents by Inventor Edmund Poon

Edmund Poon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY MOLECULES THAT BIND CD137 AND OX40
    Publication number: 20220048996
    Abstract: The present application relates to antibody molecules that bind and are able to agonise both CD137 and OX40. The antibody molecules comprise a CDR-based binding site for CD137, and an OX40 antigen-binding site that is located in a constant domain of the antibody molecule. The antibody molecules of the invention find application, for example, in the treatment of diseases, such as cancer and infectious diseases.
    Type: Application
    Filed: July 12, 2019
    Publication date: February 17, 2022
    Applicant: F-star Beta Limited
    Inventors: Mihriban Tuna, Miguel Gaspar, Michelle Morrow, Edmund Poon
  • Therapeutic combinations comprising anti-CD73 antibodies and uses thereof
    Patent number: 10864269
    Abstract: The present invention provides therapeutic combinations featuring anti-CD73 antibodies (e.g., MEDI9447) and A2A receptor inhibitors and methods of using such combinations for reducing tumor-mediated immunosuppression.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: December 15, 2020
    Assignee: MedImmune Limited
    Inventors: Kris Sachsenmeier, Erin Sult, Carl Hay, Edmund Poon
  • METHODS OF TREATMENT WITH ANTAGONISTS AGAINST PD-1 AND PD-L1 IN COMBINATION WITH RADIATION THERAPY
    Publication number: 20190192655
    Abstract: This application provides a method of treating cancer in a patient comprising administering at least one dose of radiation therapy and at least one PD-1 and/or PD-L1 antagonist, wherein at least one PD-1 and/or PD-L1 antagonist is administered on the same day as a dose of radiation therapy or up to and including 4 days later.
    Type: Application
    Filed: September 5, 2018
    Publication date: June 27, 2019
    Inventors: ROSS A. STEWART, MICHELLE MORROW, ROBERT W. WILKINSON, EDMUND POON, SIMON DOVEDI, TIM ILLIDGE
  • Methods of treatment with antagonists against PD-1 and PD-L1 in combination with radiation therapy
    Patent number: 10092645
    Abstract: This application provides a method of treating cancer in a patient comprising administering at least one dose of radiation therapy and at least one PD-1 and/or PD-L1 antagonist, wherein at least one PD-1 and/or PD-L1 antagonist is administered on the same day as a dose of radiation therapy or up to and including 4 days later.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: October 9, 2018
    Assignee: MedImmune Limited
    Inventors: Ross Stewart, Michelle Morrow, Robert Wilkinson, Edmund Poon, Simon Dovedi, Tim Illidge
  • THERAPEUTIC COMBINATIONS COMPRISING ANTI-CD73 ANTIBODIES AND USES THEREOF
    Publication number: 20180125973
    Abstract: The present invention provides therapeutic combinations featuring anti-CD73 antibodies (e.g., MED19447) and A2A receptor inhibitors and methods of using such combinations for reducing tumor-mediated immunosuppression.
    Type: Application
    Filed: September 25, 2017
    Publication date: May 10, 2018
    Applicant: MedImmune Limited
    Inventors: Kris SACHSENMEIER, Erin SULT, Carl HAY, Edmund POON
  • THERAPEUTIC COMBINATIONS COMPRISING ANTI-CD73 ANTIBODIES AND USES THEREOF
    Publication number: 20160129108
    Abstract: The present invention provides therapeutic combinations featuring anti-CD73 antibodies (e.g., MEDI9447) and A2A receptor inhibitors and methods of using such combinations for reducing tumor-mediated immunosuppression.
    Type: Application
    Filed: November 10, 2015
    Publication date: May 12, 2016
    Applicant: MedImmune Limited
    Inventors: Kris SACHSENMEIER, Erin Sult, Carl Hay, Edmund Poon
  • METHODS OF TREATMENT WITH ANTAGONISTS AGAINST PD-1 AND PD-L1 IN COMBINATION WITH RADIATION THERAPY
    Publication number: 20160051672
    Abstract: This application provides a method of treating cancer in a patient comprising administering at least one dose of radiation therapy and at least one PD-1 and/or PD-L1 antagonist, wherein at least one PD-1 and/or PD-L1 antagonist is administered on the same day as a dose of radiation therapy or up to and including 4 days later.
    Type: Application
    Filed: June 16, 2015
    Publication date: February 25, 2016
    Inventors: Ross STEWART, Michelle Morrow, Robert Wilkinson, Edmund Poon, Simon Dovedi, Tim Illidge